Director · Maze Therapeutics, Inc. · Maze Therapeutics, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
36.0K
Price
—
Executed
Aug 13, 2026
Disclosed
Aug 17, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 13 executedAug 17, 2026 disclosed
MAZE · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Maze Therapeutics, Inc. — Stock Option (Right to Buy)
Ticker
MAZE
Shares
36.0K
Price per share
$0
Execution date (reported)
Aug 13, 2026
Owned after transaction
36.0K shares
Days from execution to publication
4
What this establishes
Kornowski Sophie filed this Form 4 reporting a grant or award of MAZE on Aug 13, 2026. It became public on Aug 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kornowski Sophiecik:0001894117
Issuer
Maze Therapeutics, Inc.cik:0001842295
Revision history · 0
No field has changed since this record was first ingested.
